HCPLive

Those who received the agent in EMERGE reported a significant slowing of decline on measures of cognition and function such as memory, orientation, and language, as well as for activities of daily living.

Tests for N-methyl-Daspartate receptor, myelin oligodendrocyte glycoprotein, and aquaporin-4 autoantibodies had negative results in all patients.

The results echo the previous understanding of MS specialists as well as add to the literature that has been collected thus far from other assessments.

Those with ≥150 min per week in moderated or vigorous activities were low risk while those with less than 150 or sedentary activity were higher risk.

Our seven-part series on how the pandemic brought about telemedicine in US healthcare, and what its future use looks like.

The frequency of attacks compared to monthly can directly increase the number and severity of post-concussion symptoms.

Recent studies show efficacy and safety for both lemborexant and ozanimod.

The tau tracer can support a pathological diagnosis of Alzheimer disease by identifying the underlying presence of NFTs at the B3 level.

The new technology has applications for diagnosis and recruitment for disease-modifying trials.

Despite patients being off treatment for an average of 23 months, patients treated with Eisai’s BAN2401 remained amyloid PET negative in an open-label extension preliminary analysis.

Flortaucipir PET tracer’s can identify high levels of neuropathologic changes and neurofibrillary tangles.

The new approval is based on the result of 38 clinical trials involving more than 1000 patients.

New data finds perampanel lowers Insomnia Severity Index scores in patients.

Impulse control disorder symptoms also commonly found in Parkinson disease patients treated with dopamine agonists.

AXS-07 showed statistical significance for migraine pain freedom at 90 minutes, and at every time point after.

Better testing for SDB and other sleep disorders are needed for the older population.

Rishi Singh, MD, of Cole Eye Institute, discusses steps to take to help prevent the spread of coronavirus in ophthalmology practices.

Ponesimod reduced fatigue-related symptoms in phase 3 clinical trial.

Individuals are encouraged to maintain some semblance of normalcy in face of the coronavirus outbreak, including regular exercise and sleep.

Hospitals are preparing to treat MS patients safely in the wake of fears over the global pandemic.

MS patients who experience relapses score significantly lower on the Timed 25-Foot Walk Test.

The CDC is preparing for a hypothetical future despite American risk of local transmission not being high presently.

The task force’s recommendations will remain unchanged since the last version in 2014.

New drug more often linked to a full ON response from Parkinson disease patients at 30 minutes when compared to a placebo.

Patients in the treatment group had improved dyskinesia symptoms and off time.

New weekly report data shows the count of jurisdictions with high influenza-like illness activity has risen again.